liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Allo HSCT with RIC for poor-risk CLL in Sweden: donor T-cell engraftment 3 months after transplantation predicts long-term survival in BONE MARROW TRANSPLANTATION, vol 46, issue , pp S365-S365
Hematol Centre, Stockholm, Sweden .
Hematol Centre, Stockholm, Sweden .
Hematol Centre, Stockholm, Sweden .
Department Hematol, Uppsala, Sweden .
Show others and affiliations
2011 (English)In: BONE MARROW TRANSPLANTATION, Nature Publishing Group , 2011, Vol. 46, S365-S365 p.Conference paper, Published paper (Refereed)
Abstract [en]

n/a

Place, publisher, year, edition, pages
Nature Publishing Group , 2011. Vol. 46, S365-S365 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-68027ISI: 000289195402315OAI: oai:DiVA.org:liu-68027DiVA: diva2:415220
Available from: 2011-05-06 Created: 2011-05-06 Last updated: 2011-05-06

Open Access in DiVA

No full text

By organisation
OncologyFaculty of Health Sciences
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 16 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf